News & Stories

With communities and economies everywhere affected by the growing COVID-19 pandemic, Danaher will donate to four organizations focused on COVID-19 relief efforts.

The test is the first rapid point-of-care solution to receive EUA FDA approval and is designed to operate on any of Cepheid's more than 23,000 automated GeneXpert® Systems worldwide, with a detection time of approximately 45 minutes.

Our Global Response Team is committed to protecting associate safety and well-being by actively monitoring, preparing and managing our global COVID-19 business response 24/7 based on direction from international health organizations, local governments and our own safety protocols.

Meet the reassuring hue that instills calm, confidence and connection and learn why it was chosen.

Danaher's Senior Vice President of Human Resources has been recognized for building on Danaher's strengths while expanding HR’s strategic business focus.